Call Now Open
Oxford-Harrington Rare Disease Scholar Award
Medicines in the making
Institutions supported
Companies launched
Medicines in the clinic
Licenses to pharma
In addition to receiving funding, every scholar is paired with a results-oriented and mission-focused team from our Therapeutics Development Center. Teams consist of a project manager and experienced pharma and business development advisors with a track record of bringing new drugs to market.
Learn MoreOur pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.
See all discoveriesOur pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.
See all discoveriesDr. Paul Tesar of Case Western Reserve University and Dr. Donald F. Weaver of University Health Network selected for their work targeting novel pathways in Alzheimer’s
Continue ReadingDr. Paul Tesar of Case Western Reserve University and Dr. Donald F. Weaver of University Health Network selected for their work targeting novel pathways in Alzheimer’s
Continue ReadingNew Scholar Award Accelerates Novel Therapies for Rare Diseases
Continue ReadingCo-founder and president of Harrington Discovery Institute at University Hospitals receives highest professional distinction awarded solely to inventors
Continue Reading